These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30222715)

  • 1. Clinical Characteristics and Outcomes of Moraxella Keratitis.
    Zafar H; Tan SZ; Walkden A; Fullwood C; Au L; Brahma A; Carley F
    Cornea; 2018 Dec; 37(12):1551-1554. PubMed ID: 30222715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry.
    Takahashi S; Murata K; Ozawa K; Yamada H; Kawakami H; Nakayama A; Asano Y; Mochizuki K; Mikamo H
    Jpn J Ophthalmol; 2019 Jul; 63(4):328-336. PubMed ID: 31273564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moraxella keratitis: risk factors, presentation, and management.
    Mian SI; Malta JB
    Acta Ophthalmol; 2011 Mar; 89(2):e208-9. PubMed ID: 19930213
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Characteristics of 17 Patients with Moraxella Keratitis.
    Tobimatsu Y; Inada N; Shoji J; Yamagami S
    Semin Ophthalmol; 2018; 33(5):726-732. PubMed ID: 29308970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis.
    Inoue H; Suzuki T; Inoue T; Hattori T; Nejima R; Todokoro D; Hoshi S; Eguchi H; Miyamoto H; Ohashi Y
    Cornea; 2015 Sep; 34(9):1105-9. PubMed ID: 25970435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological characteristics of Moraxella keratitis.
    McSwiney TJ; Knowles SJ; Murphy CC
    Br J Ophthalmol; 2019 Dec; 103(12):1704-1709. PubMed ID: 30709811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Outcomes of Kocuria Keratitis and Comparison With Coagulase-Negative Staphylococci Keratitis.
    Kate A; Bagga B; Joseph J; Mohamed A
    Cornea; 2020 Aug; 39(8):957-960. PubMed ID: 32243425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moraxella keratitis: epidemiology and outcomes.
    Hoarau G; Merabet L; Brignole-Baudouin F; Mizrahi A; Borderie V; Bouheraoua N
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2317-2325. PubMed ID: 32648113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome of Moraxella keratitis: our experience with 18 cases--a retrospective review.
    Garg P; Mathur U; Athmanathan S; Rao GN
    Cornea; 1999 Mar; 18(2):176-81. PubMed ID: 10090363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes.
    Durrani AF; Faith SC; Kowalski RP; Yu M; Romanowski E; Shanks R; Dhaliwal D; Jhanji V
    Am J Ophthalmol; 2019 Jan; 197():17-22. PubMed ID: 30201340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
    Lieb DF; Scott IU; Flynn HW; Miller D; Feuer WJ
    Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas maltophilia-A Case Series of a Rare Keratitis Affecting Patients With Bandage Contact Lens.
    Hogg HDJ; Siah WF; Okonkwo A; Narayanan M; Figueiredo FC
    Eye Contact Lens; 2019 Jan; 45(1):e1-e4. PubMed ID: 29369229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Features, Antibiotic Susceptibility Profiles, and Outcomes of Infectious Keratitis Caused by Achromobacter xylosoxidans.
    Spierer O; Monsalve PF; OʼBrien TP; Alfonso EC; Gologorsky D; Miller D
    Cornea; 2016 May; 35(5):626-30. PubMed ID: 26989957
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Das S; Rao AS; Sahu SK; Sharma S
    Br J Ophthalmol; 2016 Jul; 100(7):939-943. PubMed ID: 26567025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moraxella keratitis: predisposing factors and clinical review of 95 cases.
    Das S; Constantinou M; Daniell M; Taylor HR
    Br J Ophthalmol; 2006 Oct; 90(10):1236-8. PubMed ID: 16825274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and microbiological study of paediatric infectious keratitis in South India: a 3-year study (2011-2013).
    Aruljyothi L; Radhakrishnan N; Prajna VN; Lalitha P
    Br J Ophthalmol; 2016 Dec; 100(12):1719-1723. PubMed ID: 26917675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of bilateral keratitis caused by Providencia alcalifaciens: a rarely encountered ocular pathogen.
    Choi W; Ji YS; Yoon KC
    Int Ophthalmol; 2018 Jun; 38(3):1325-1328. PubMed ID: 28516225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Pseudomonas aeruginosa genotype with antibiotic susceptibility and clinical features of induced central keratitis.
    Shen EP; Hsieh YT; Chu HS; Chang SC; Hu FR
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):365-71. PubMed ID: 25537202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiologic identification of bleb-related delayed-onset endophthalmitis caused by moraxella species.
    Cornut PL; Chiquet C; Bron A; Romanet JP; Lina G; Lafontaine PO; Benito Y; Pechinot A; Burillon C; Vandenesch F; Denis P;
    J Glaucoma; 2008; 17(7):541-5. PubMed ID: 18854730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.